Monthly
US$200
Billed every month
Loratadine Tablets(氯雷他定片)
Companies, stages and changes, with each record available on this page.
Last 90 days: Accepted: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders12View records ↓
Under-review filings6View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers34View records ↓
API companies with A status34View records ↓
Chemical-drug catalogue
Loaded records: 12 holders; 10 in the quality-and-efficacy consistency-evaluation category, and 0 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 北京星昊医药股份有限公司 | 北京星昊医药股份有限公司 | 国药准字H20050039 | 2025/07/18 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 昆明积大制药股份有限公司 | 昆明积大制药股份有限公司 | 国药准字H20040393 | 2025/07/18 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 海南海神同洲制药有限公司 | 海南海神同洲制药有限公司 | 国药准字H20040797 | 2025/03/03 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江苏亚邦爱普森药业有限公司 | 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 2023/08/16 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 北大医药股份有限公司 | 北大医药股份有限公司 | 国药准字H20040784 | 2022/09/29 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 广东逸舒制药股份有限公司 | 广东逸舒制药股份有限公司 | 国药准字H20052214 | 2022/03/03 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 三门峡赛诺维制药有限公司 | 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 2022/03/03 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江苏黄河药业股份有限公司 | 江苏黄河药业股份有限公司 | 国药准字H20050953 | 2021/05/21 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 万特制药（海南）有限公司 | 万特制药（海南）有限公司 | 国药准字H20060402 | 2020/06/11 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 扬子江药业集团上海海尼药业有限公司 | 扬子江药业集团上海海尼药业有限公司 | 国药准字H20080134 | 2019/12/16 | 10mg | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| — | 拜耳医药（上海）有限公司 | 国药准字H10970410 | 1996/12/17 | 10mg | Other drug (其他药品) | CDE |
| Bayer SA-NV | Schering-Plough Labo N.V. | H20160424 | 1993/01/03 | 10mg | Imported originator drug (进口原研药品) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 34 distinct approval numbers and 34 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 北京星昊医药股份有限公司 | 国药准字H20050039 | 10mg | Category A (甲) | XR06AXL226A001010100198 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001010100363 | NHSA |
| 深圳市海滨制药有限公司 | 国药准字H20031299 | 10mg | Category A (甲) | XR06AXL226A001010100523 | NHSA |
| 拜耳医药(上海)有限公司 | 国药准字H10970410 | 10mg | Category A (甲) | XR06AXL226A001010100784 | NHSA |
| 扬子江药业集团上海海尼药业有限公司 | 国药准字H20080134 | 10mg | Category A (甲) | XR06AXL226A001010100841 | NHSA |
| 北大医药股份有限公司 | 国药准字H20040784 | 10mg | Category A (甲) | XR06AXL226A001010100976 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001010101243 | NHSA |
| 费森尤斯卡比华瑞制药有限公司 | 国药准字H20040557 | 10mg | Category A (甲) | XR06AXL226A001010101415 | NHSA |
| 江苏黄河药业股份有限公司 | 国药准字H20050953 | 10mg | Category A (甲) | XR06AXL226A001010101450 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001010101467 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H20041016 | 10mg | Category A (甲) | XR06AXL226A001010101492 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001010101510 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20031112 | 10mg | Category A (甲) | XR06AXL226A001010101523 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20041659 | 10mg | Category A (甲) | XR06AXL226A001010101583 | NHSA |
| 常州四药制药有限公司 | 国药准字H20030004 | 10mg | Category A (甲) | XR06AXL226A001010101749 | NHSA |
| 成都恒瑞制药有限公司 | 国药准字H20030112 | 10mg | Category A (甲) | XR06AXL226A001010102031 | NHSA |
| 成都永康制药有限公司 | 国药准字H20051618 | 10mg | Category A (甲) | XR06AXL226A001010102076 | NHSA |
| 四川维奥制药有限公司 | 国药准字H20052120 | 10mg | Category A (甲) | XR06AXL226A001010102264 | NHSA |
| 西安杨森制药有限公司 | 国药准字H20070030 | 10mg | Category A (甲) | XR06AXL226A001010102529 | NHSA |
| 山西振东泰盛制药有限公司 | 国药准字H20080105 | 10mg | Category A (甲) | XR06AXL226A001010102946 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001010103036 | NHSA |
| 天方药业有限公司 | 国药准字H20067066 | 10mg | Category A (甲) | XR06AXL226A001010103098 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001010103190 | NHSA |
| 青岛双鲸药业股份有限公司 | 国药准字H20040498 | 10mg | Category A (甲) | XR06AXL226A001010104052 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001010104121 | NHSA |
| 山东天顺药业股份有限公司 | 国药准字H20051688 | 10mg | Category A (甲) | XR06AXL226A001010104174 | NHSA |
| 浙江弘盛药业有限公司 | 国药准字H20052157 | 10mg | Category A (甲) | XR06AXL226A001010104645 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20030213 | 10mg | Category A (甲) | XR06AXL226A001010104658 | NHSA |
| 昆明积大制药股份有限公司 | 国药准字H20040393 | 10mg | Category A (甲) | XR06AXL226A001010105589 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001010105777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001010105830 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001010105848 | NHSA |
| 北京星昊医药股份有限公司 | 国药准字H20050039 | 10mg | Category A (甲) | XR06AXL226A001010200198 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001010200363 | NHSA |
| 深圳市海滨制药有限公司 | 国药准字H20031299 | 10mg | Category A (甲) | XR06AXL226A001010200523 | NHSA |
| 拜耳医药(上海)有限公司 | 国药准字H10970410 | 10mg | Category A (甲) | XR06AXL226A001010200784 | NHSA |
| 扬子江药业集团上海海尼药业有限公司 | 国药准字H20080134 | 10mg | Category A (甲) | XR06AXL226A001010200841 | NHSA |
| 北大医药股份有限公司 | 国药准字H20040784 | 10mg | Category A (甲) | XR06AXL226A001010200976 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001010201243 | NHSA |
| 江苏黄河药业股份有限公司 | 国药准字H20050953 | 10mg | Category A (甲) | XR06AXL226A001010201450 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001010201467 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H20041016 | 10mg | Category A (甲) | XR06AXL226A001010201492 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001010201510 | NHSA |
| 正大天晴药业集团股份有限公司 | 国药准字H20031112 | 10mg | Category A (甲) | XR06AXL226A001010201523 | NHSA |
| 南京圣和药业股份有限公司 | 国药准字H20041659 | 10mg | Category A (甲) | XR06AXL226A001010201583 | NHSA |
| 成都恒瑞制药有限公司 | 国药准字H20030112 | 10mg | Category A (甲) | XR06AXL226A001010202031 | NHSA |
| 成都永康制药有限公司 | 国药准字H20051618 | 10mg | Category A (甲) | XR06AXL226A001010202076 | NHSA |
| 四川维奥制药有限公司 | 国药准字H20052120 | 10mg | Category A (甲) | XR06AXL226A001010202264 | NHSA |
| 西安澜泰药业有限公司 | 国药准字H20051927 | 10mg | Category A (甲) | XR06AXL226A001010202498 | NHSA |
| 西安杨森制药有限公司 | 国药准字H20070030 | 10mg | Category A (甲) | XR06AXL226A001010202529 | NHSA |
| 山西振东泰盛制药有限公司 | 国药准字H20080105 | 10mg | Category A (甲) | XR06AXL226A001010202946 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001010203036 | NHSA |
| 天方药业有限公司 | 国药准字H20067066 | 10mg | Category A (甲) | XR06AXL226A001010203098 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001010203190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001010204121 | NHSA |
| 山东天顺药业股份有限公司 | 国药准字H20051688 | 10mg | Category A (甲) | XR06AXL226A001010204174 | NHSA |
| 浙江弘盛药业有限公司 | 国药准字H20052157 | 10mg | Category A (甲) | XR06AXL226A001010204645 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20030213 | 10mg | Category A (甲) | XR06AXL226A001010204658 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001010204864 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001010205777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001010205830 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001010205848 | NHSA |
| 北京星昊医药股份有限公司 | 国药准字H20050039 | 10mg | Category A (甲) | XR06AXL226A001010300198 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001010300363 | NHSA |
| 扬子江药业集团上海海尼药业有限公司 | 国药准字H20080134 | 10mg | Category A (甲) | XR06AXL226A001010300841 | NHSA |
| 北大医药股份有限公司 | 国药准字H20040784 | 10mg | Category A (甲) | XR06AXL226A001010300976 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001010301243 | NHSA |
| 江苏黄河药业股份有限公司 | 国药准字H20050953 | 10mg | Category A (甲) | XR06AXL226A001010301450 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001010301467 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H20041016 | 10mg | Category A (甲) | XR06AXL226A001010301492 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001010301510 | NHSA |
| 成都永康制药有限公司 | 国药准字H20051618 | 10mg | Category A (甲) | XR06AXL226A001010302076 | NHSA |
| 四川维奥制药有限公司 | 国药准字H20052120 | 10mg | Category A (甲) | XR06AXL226A001010302264 | NHSA |
| 西安澜泰药业有限公司 | 国药准字H20051927 | 10mg | Category A (甲) | XR06AXL226A001010302498 | NHSA |
| 山西振东泰盛制药有限公司 | 国药准字H20080105 | 10mg | Category A (甲) | XR06AXL226A001010302946 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001010303036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001010303190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001010304121 | NHSA |
| 山东天顺药业股份有限公司 | 国药准字H20051688 | 10mg | Category A (甲) | XR06AXL226A001010304174 | NHSA |
| 浙江弘盛药业有限公司 | 国药准字H20052157 | 10mg | Category A (甲) | XR06AXL226A001010304645 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20030213 | 10mg | Category A (甲) | XR06AXL226A001010304658 | NHSA |
| 昆明积大制药股份有限公司 | 国药准字H20040393 | 10mg | Category A (甲) | XR06AXL226A001010305589 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001010305777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001010305830 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001010305848 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001010400363 | NHSA |
| 北大医药股份有限公司 | 国药准字H20040784 | 10mg | Category A (甲) | XR06AXL226A001010400976 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001010401243 | NHSA |
| 江苏黄河药业股份有限公司 | 国药准字H20050953 | 10mg | Category A (甲) | XR06AXL226A001010401450 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001010401467 | NHSA |
| 苏中药业集团股份有限公司 | 国药准字H20041016 | 10mg | Category A (甲) | XR06AXL226A001010401492 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001010401510 | NHSA |
| 成都永康制药有限公司 | 国药准字H20051618 | 10mg | Category A (甲) | XR06AXL226A001010402076 | NHSA |
| 四川维奥制药有限公司 | 国药准字H20052120 | 10mg | Category A (甲) | XR06AXL226A001010402264 | NHSA |
| 山西振东泰盛制药有限公司 | 国药准字H20080105 | 10mg | Category A (甲) | XR06AXL226A001010402946 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001010403036 | NHSA |
| 天方药业有限公司 | 国药准字H20067066 | 10mg | Category A (甲) | XR06AXL226A001010403098 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001010403190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001010404121 | NHSA |
| 浙江弘盛药业有限公司 | 国药准字H20052157 | 10mg | Category A (甲) | XR06AXL226A001010404645 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20030213 | 10mg | Category A (甲) | XR06AXL226A001010404658 | NHSA |
| 昆明积大制药股份有限公司 | 国药准字H20040393 | 10mg | Category A (甲) | XR06AXL226A001010405589 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001010405777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001010405830 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001010405848 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001010500363 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001010501243 | NHSA |
| 江苏黄河药业股份有限公司 | 国药准字H20050953 | 10mg | Category A (甲) | XR06AXL226A001010501450 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001010501467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001010501510 | NHSA |
| 成都永康制药有限公司 | 国药准字H20051618 | 10mg | Category A (甲) | XR06AXL226A001010502076 | NHSA |
| 山西振东泰盛制药有限公司 | 国药准字H20080105 | 10mg | Category A (甲) | XR06AXL226A001010502946 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001010503036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001010503190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001010504121 | NHSA |
| 浙江弘盛药业有限公司 | 国药准字H20052157 | 10mg | Category A (甲) | XR06AXL226A001010504645 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20030213 | 10mg | Category A (甲) | XR06AXL226A001010504658 | NHSA |
| 昆明积大制药股份有限公司 | 国药准字H20040393 | 10mg | Category A (甲) | XR06AXL226A001010505589 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001010505777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001010505830 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001010505848 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001010600363 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001010601243 | NHSA |
| 江苏黄河药业股份有限公司 | 国药准字H20050953 | 10mg | Category A (甲) | XR06AXL226A001010601450 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001010601467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001010601510 | NHSA |
| 成都永康制药有限公司 | 国药准字H20051618 | 10mg | Category A (甲) | XR06AXL226A001010602076 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001010603036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001010603190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001010604121 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20030213 | 10mg | Category A (甲) | XR06AXL226A001010604658 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001010605777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001010605830 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001010605848 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001010700363 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001010701243 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001010701467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001010701510 | NHSA |
| 成都永康制药有限公司 | 国药准字H20051618 | 10mg | Category A (甲) | XR06AXL226A001010702076 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001010703036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001010703190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001010704121 | NHSA |
| 浙江京新药业股份有限公司 | 国药准字H20030213 | 10mg | Category A (甲) | XR06AXL226A001010704658 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001010705777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001010705830 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001010705848 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001010800363 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001010801243 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001010801467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001010801510 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001010803036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001010803190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001010804121 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001010805777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001010805830 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001010805848 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001010900363 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001010901243 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001010901467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001010901510 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001010903036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001010903190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001010904121 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001010905777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001010905830 | NHSA |
| 广东逸舒制药股份有限公司 | 国药准字H20052214 | 10mg | Category A (甲) | XR06AXL226A001011000363 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001011001243 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001011001467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001011001510 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001011003036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001011003190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001011004121 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001011005777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001011005830 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001011101243 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001011101467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001011101510 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001011103036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001011103190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001011104121 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001011105777 | NHSA |
| 海南新世通制药有限公司 | 国药准字H20041886 | 10mg | Category A (甲) | XR06AXL226A001011105830 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001011201243 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001011201467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001011201510 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001011203036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001011203190 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001011204121 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001011205777 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001011301243 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001011301467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001011301510 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001011303036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001011303190 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001011305777 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001011401243 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001011401467 | NHSA |
| 江苏亚邦爱普森药业有限公司 | 国药准字H20045777 | 10mg | Category A (甲) | XR06AXL226A001011401510 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001011403036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001011403190 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001011405777 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001011501243 | NHSA |
| 江苏联环药业股份有限公司 | 国药准字H20040755 | 10mg | Category A (甲) | XR06AXL226A001011501467 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001011503036 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001011503190 | NHSA |
| 海南海神同洲制药有限公司 | 国药准字H20040797 | 10mg | Category A (甲) | XR06AXL226A001011505777 | NHSA |
| 辽宁海一制药有限公司 | 国药准字H20041396 | 10mg | Category A (甲) | XR06AXL226A001011601243 | NHSA |
| 三门峡赛诺维制药有限公司 | 国药准字H20020174 | 10mg | Category A (甲) | XR06AXL226A001011603190 | NHSA |
| 河南九势制药股份有限公司 | 国药准字H20050009 | 10mg | Category A (甲) | XR06AXL226A001020103036 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001020104121 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001020104864 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001020105848 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001020204864 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001020205848 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001020304864 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001020404864 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001020504864 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001020604864 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001020704864 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001020804864 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001020904864 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001020905848 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001021005848 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001021104864 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001021105848 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001021304121 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001021404121 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001021504121 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001021604121 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001021704121 | NHSA |
| 山东良福制药有限公司 | 国药准字H20051125 | 10mg | Category A (甲) | XR06AXL226A001021804121 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001030104864 | NHSA |
| 万特制药(海南)有限公司 | 国药准字H20060402 | 10mg | Category A (甲) | XR06AXL226A001030105848 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001030204864 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001030304864 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001031204864 | NHSA |
| 万全万特制药(厦门)有限公司 | 国药准字H20050233 | 10mg | Category A (甲) | XR06AXL226A001031304864 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 6 filings and 6 distinct first applicants.
Generic 3 · Supplement 3
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 江苏万高药业股份有限公司 | CYHS2601192 | Generic | 2026/05/25 | Not stated by source | CDE |
| 江苏联环药业股份有限公司 | CYHB2650121 | Supplement | 2026/05/18 | Not stated by source | CDE |
| 辰欣药业股份有限公司 | CYHS2602061 | Generic | 2026/08/20 | Not stated by source | CDE |
| 湖南千金湘江药业股份有限公司;华益药业科技（安徽）有限公司 | CYHB2601519 | Supplement | 2026/08/10 | Not stated by source | CDE |
| 山东良福制药有限公司 | CYHB2650010 | Supplement | 2026/01/09 | Not stated by source | CDE |
| 华益药业科技（安徽）有限公司 | CYHS2502486 | Generic | 2025/07/12 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 2 filings and 2 distinct first applicants.
API registrations
Non-component matches: 34 companies with A status and 1 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 氯雷他定 | Tagoor Laboratories Private Limited | Y20240001028 | I | Exact ingredient | 2024/12/09 | CDE |
| 氯雷他定 | Morepen Laboratories Ltd | Y20230000137 | A | Exact ingredient | 2025/03/14 | CDE |
| 氯雷他定 | 南京亿华药业有限公司 | Y20230000259 | A | Exact ingredient | 2024/09/02 | CDE |
| 氯雷他定 | Matrix Pharmacorp Private Limited | Y20190000502 | A | Exact ingredient | 2026/06/02 | CDE |
| 氯雷他定 | Vasudha Pharma Chem Limited | Y20190009997 | A | Exact ingredient | 2026/07/30 | CDE |
| 氯雷他定 | Schering-Plough Europe | Y20190009311 | A | Exact ingredient | — | CDE |
| 氯雷他定 | 常州亚邦制药有限公司 | Y20190008725 | A | Exact ingredient | 2025/07/24 | CDE |
| 氯雷他定 | 三门峡赛诺维制药有限公司 | Y20190008555 | A | Exact ingredient | 2024/11/01 | CDE |
| 氯雷他定 | 浙江东亚药业股份有限公司 | Y20190008454 | A | Exact ingredient | 2024/12/07 | CDE |
| 氯雷他定 | 湖南华纳大药厂手性药物有限公司 | Y20190008305 | A | Exact ingredient | 2024/11/28 | CDE |
| 氯雷他定 | 山西振东泰盛制药有限公司 | Y20190008269 | A | Exact ingredient | 2023/03/24 | CDE |
| 氯雷他定 | 南京圣和药业股份有限公司 | Y20190008187 | A | Exact ingredient | 2026/05/18 | CDE |
| 氯雷他定 | 成都奥邦药业有限公司 | Y20190008149 | A | Exact ingredient | 2025/12/26 | CDE |
| 氯雷他定 | 四川维奥制药有限公司 | Y20190008142 | A | Exact ingredient | 2025/10/10 | CDE |
| 氯雷他定 | 万特制药（海南）有限公司 | Y20190008138 | A | Exact ingredient | 2025/09/16 | CDE |
| 氯雷他定 | 湖南九典宏阳制药有限公司 | Y20190008134 | A | Exact ingredient | 2025/07/28 | CDE |
| 氯雷他定 | 珠海保税区丽珠合成制药有限公司 | Y20190008122 | A | Exact ingredient | 2024/11/21 | CDE |
| 氯雷他定 | 绍兴京新药业有限公司 | Y20190008097 | A | Exact ingredient | 2024/06/12 | CDE |
| 氯雷他定 | 河北元森制药有限公司 | Y20190008088 | A | Exact ingredient | 2025/05/07 | CDE |
| 氯雷他定 | 深圳海王药业有限公司 | Y20190008061 | A | Exact ingredient | 2024/12/27 | CDE |
| 氯雷他定 | 江苏恒瑞医药股份有限公司 | Y20190008022 | A | Exact ingredient | — | CDE |
| 氯雷他定 | 国药集团致君（苏州）制药有限公司 | Y20190007939 | A | Exact ingredient | — | CDE |
| 氯雷他定 | 天方药业有限公司 | Y20190007867 | A | Exact ingredient | 2026/02/03 | CDE |
| 氯雷他定 | 昆明积大制药股份有限公司 | Y20190007865 | A | Exact ingredient | 2025/06/21 | CDE |
| 氯雷他定 | 深圳信立泰药业股份有限公司 | Y20190007851 | A | Exact ingredient | 2024/09/12 | CDE |
| 氯雷他定 | 万全万特制药（厦门）有限公司 | Y20190007841 | A | Exact ingredient | 2024/09/28 | CDE |
| 氯雷他定 | 广东华润顺峰药业有限公司 | Y20190007837 | A | Exact ingredient | 2024/08/15 | CDE |
| 氯雷他定 | 浙江海正药业股份有限公司 | Y20190007818 | A | Exact ingredient | — | CDE |
| 氯雷他定 | 河南九势制药股份有限公司 | Y20190007802 | A | Exact ingredient | 2025/01/15 | CDE |
| 氯雷他定 | 山东罗欣药业集团恒欣药业有限公司 | Y20190007796 | A | Exact ingredient | 2025/02/20 | CDE |
| 氯雷他定 | 海南卓科制药有限公司 | Y20190007772 | A | Exact ingredient | 2025/03/07 | CDE |
| 氯雷他定 | 重庆西南合成制药有限公司 | Y20190007758 | A | Exact ingredient | — | CDE |
| 氯雷他定 | 浙江昌明药业有限公司 | Y20190007728 | A | Exact ingredient | — | CDE |
| 盐酸氯雷他定 | 济南恒基制药有限公司 | Y20190002301 | A | Salt-normalized ingredient | 2025/05/13 | CDE |
| 氯雷他定 | 江苏兢业制药有限公司 | Y20170002304 | A | Exact ingredient | 2023/12/19 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/08/20Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Loratadine Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy